Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 3,000 | 590 | 430 | 2 |
| Marketable Securities | 53,840 | 57,410 | 21,220 | 31,890 |
| Receivables | 4,500 | 2,200 | 450 | 290 |
| Other current assets | 1,270 | 2,330 | 1,670 | 1,619 |
| TOTAL | $62,610 | $62,530 | $23,770 | $33,800 |
| Non-Current Assets | ||||
| PPE Net | 2,890 | 3,230 | 3,460 | 2,850 |
| Other Non-Current Assets | 2,170 | 1,850 | 1,650 | 1,450 |
| TOTAL | $5,060 | $5,080 | $5,110 | $4,300 |
| Total Assets | $67,680 | $67,610 | $28,890 | $38,110 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 7,180 | 4,470 | 3,190 | 2,160 |
| Other current liabilities | 4,020 | 3,970 | 540 | 1,320 |
| TOTAL | $11,210 | $8,440 | $3,740 | $3,710 |
| Non-Current Liabilities | ||||
| aiOther Non-Current Liabilities | 14,110 | 16,800 | 1,980 | 1,660 |
| TOTAL | $14,110 | $16,800 | $1,980 | $1,665 |
| Total Liabilities | $25,330 | $25,250 | $5,720 | $5,380 |
| Shareholders' Equity | ||||
| Common Shares | 110,530 | 87,570 | 61,420 | 57,250 |
| Retained earnings | -75,990 | -52,190 | -42,670 | -28,000 |
| Other shareholders' equity | -90 | 10 | 10 | 0 |
| TOTAL | $42,350 | $42,360 | $23,170 | $32,730 |
| Total Liabilities And Equity | $67,680 | $67,610 | $28,890 | $38,110 |